Genprex Provides Clinical Update on Diabetes Gene Therapy Program
Company Achieves Clinical Development Milestones in 2025, Advances Program for Future Scale Up and Studies AUSTIN, Texas, Jan. 7, 2026 /PRNewswire/ — Genprex,... Read more.
Criteo Provides Update on Luxembourg Redomiciliation
Shareholder Meeting to be Convened on February 27, 2026 NEW YORK, Jan. 7, 2026 /PRNewswire/ — Criteo S.A. (NASDAQ: CRTO) (“Criteo” or the “Company“),... Read more.
WARNER BROS. DISCOVERY BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS SHAREHOLDERS REJECT AMENDED PARAMOUNT TENDER OFFER
Offer Remains Inferior to Netflix Merger Agreement Across Numerous Key Areas Value is Insufficient Given Significant Costs, Risks and Uncertainties Heightened Risk... Read more.
RTX Recommends Shareholders Reject “Mini-Tender” Offer by Tutanota LLC
ARLINGTON, Va., Jan. 7, 2026 /PRNewswire/ — RTX (NYSE: RTX) has received notice of an unsolicited “mini-tender” offer made by Tutanota LLC (Tutanota)... Read more.
Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders
Partnership addresses the unmet need for remyelination therapies for multiple sclerosis and other demyelinating conditions by leveraging generative chemistry design... Read more.
Ping Identity Marks Digital Trust Milestone with Zero-Knowledge Biometrics in the Age of AI
Completion of the Keyless acquisition adds privacy-preserving biometric authentication andre-verification to strengthen enterprise defenses against AI-powered spoofing... Read more.
eInfochips Named “IoT Development Service Provider of the Year” at 2026 IoT Breakthrough Awards
SAN JOSE, Calif. and EINDHOVEN, Netherlands, Jan. 7, 2026 /PRNewswire/ — eInfochips, an Arrow Electronics company and a leading provider of engineering research... Read more.
Bayer and Cradle enter collaboration to enhance AI-enabled antibody discovery and optimization
Cradle provides a scientific AI software platform focused on protein engineering Bayer continues to utilize AI in R&D, reinforcing commitment to modernize and... Read more.
Nanoscope Therapeutics Granted New U.S. Patent Covering Its Proprietary Multi-Characteristic Opsin Platform for Vision Restoration
DALLAS, Jan. 7, 2026 /PRNewswire/ — Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic... Read more.
Aprio Expands in Pacific Northwest, Uniting Two Leading Oregon Firms – Delap LLP and Hoffman, Stewart & Schmidt, P.C.
ATLANTA and PORTLAND, Ore., Jan. 7, 2026 /PRNewswire/ — Aprio, the 24th largest business advisory and accounting firm in the U.S., announced today its entry... Read more.